HDAC9 and bacterial infectious disease: To understand whether these bacterial classical deacylases with different oligomeric states, substrate specificities and acyl-chain preferences can be inhibited by known mammalian classical HDAC inhibitors, we next performed inhibition studies to evaluate potential drug-repurposing strategies to fight bacterial infections.